Oral anticoagulants and risk of nephropathy.

about

Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Bioptically Proven "Anticoagulation-Related Nephropathy" Induced by Dual Antiplatelet Therapy

P2860

Q38975409-93C04F9D-3659-4620-906D-AD295FA826A9 Q58585879-CD3FBF12-0F1D-4FCE-A7C9-693542BF5364

P2860

Oral anticoagulants and risk of nephropathy.

Item

http://www.wikidata.org/entity/Q38443104

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Oral anticoagulants and risk of nephropathy.

@en

type

Item

label

Oral anticoagulants and risk of nephropathy.

@en

prefLabel

Oral anticoagulants and risk of nephropathy.

@en

P1476

Oral anticoagulants and risk of nephropathy.

@en

P2093

Dana V Rizk

http://www.w3.org/2001/XMLSchema#string

David G Warnock

http://www.w3.org/2001/XMLSchema#string

Nakshatra Saxena

http://www.w3.org/2001/XMLSchema#string

Vinay Narasimha Krishna

http://www.w3.org/2001/XMLSchema#string

P2860

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Physiology and pathophysiology of heme: implications for kidney disease

Gas6, warfarin, and kidney diseases.

A clinician's perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation--full speed ahead or proceed with caution?

Warfarin dosing in patients with impaired kidney function

Cholesterol emboli associated with warfarin treatment.

The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients.

Protease-activated receptors in hemostasis, thrombosis and vascular biology.

Anticoagulants and acute kidney injury: clinical and pathology considerations.

P2888

s40264-015-0290-z

P304

527-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40264-015-0290-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275525935

http://www.w3.org/2001/XMLSchema#string

P6179

1010314346

http://www.w3.org/2001/XMLSchema#string

P698

25913726

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Oral anticoagulants and risk of nephropathy.

about

P2860

P2860

Oral anticoagulants and risk of nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921